Granulocyte–colony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile

Granulocyte–colony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile

Successful gene therapy for β-thalassemia requires optimal numbers of autologous gene-transduced hematopoietic stem and progenitor cells (HSPCs) with high repopulating capacity. Previous studies suggested superior mobilization in these patients by the combination of granulocyte–colony stimulating fa...

Full description

Bibliographic Details
Main Authors: Elena Baiamonte, Rita Barone, Flavia Contino, Rosalia Di Stefano, Anna Marfia, Aldo Filosa, Emanuela D'Angelo, Salvatore Feo, Santina Acuto, Aurelio Maggio
Format: Article
Language:English
Published: PAGEPress Publications 2017-05-01
Series:Thalassemia Reports
Subjects:
β-thalassemia
CD34+ cells expression profiling
G-CSF+plerixafor mobilization
gene therapy.
Online Access:http://www.pagepressjournals.org/index.php/thal/article/view/6392

Internet

http://www.pagepressjournals.org/index.php/thal/article/view/6392

Similar Items